| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.00046 | 1 |